Variable | Population | Patients with ID | Patients without ID | P-value |
---|---|---|---|---|
(n = 502) | (n = 186) | (n = 316) | ||
Cardiopulmonary bypassb | 437 (87%) | 157 (84%) | 280 (89%) | 0.22 |
Circulatory arrestb | 16 (3%) | 5 (3%) | 11 (3%) | 0.82 |
Biological data | ||||
Intraoperative | ||||
Haematocrit during CPBa | 29 ± 5 || 29 (26–32) | 28 ± 5 || 28(25–31) | 29 ± 4 || 29(26–33) | 0.001 |
Postoperative (ICU) | ||||
Immediate PO Hb (g dl−1)a | 11.4 ± 1.4 || 11.4(10.5–12.4) | 11.3 ± 1.5 || 11.2(10.2–12.3) | 11.5 ± 1.4 || 11.5(10.7–12.4) | 0.08 |
Minimum ICU Hb (g dl−1)a | 10.6 ± 6 || 10.1(9–11.2) | 9.8 ± 1.5 || 9.6(8.9–10.9) | 11 ± 7.6 || 10.4(9.1–11.5) | < 0.001 |
Postoperative (surgical ward) | ||||
Minimum Hb (g dl−1)a | 10.1 ± 1.4 || 10(9–11.1) | 9.8 ± 1.3 || 9.7(8.9–10.8) | 10.2 ± 1.5 || 10.1(9.1–11.3) | 0.019 |
Discharge Hb (g dl−1)a | 10.6 ± 1.4 || 10.5(9.5–11.5) | 10.3 ± 1.3 || 10.2(9.3–11.3) | 10.7 ± 1.4 || 10.8(9.7–11.7) | < 0.001 |
Postoperative outcomes | ||||
24 h bleeding (ml) * | 547 ± 393 || 460(310–669) | 507 ± 401 || 420(300–600) | 570 ± 387 || 472(340–690) | 0.08 |
Haemostasis surgery within 24hb | 13 (3%) | 5 (3%) | 8 (3%) | 0.92 |
Postoperative infectionb | 40 (8%) | 18 (10%) | 22 (7%) | 0.36 |
Postoperative AKFb | 57 (11%) | 24 (13%) | 33 (10%) | 0.49 |
Highest creatinine level (μmol l−1)a | 96 ± 68 || 83(70–101) | 91 ± 50 || 80(68–101) | 99 ± 77 || 83(72–101) | 0.21 |
Length of stay in ICU (days)a | 3.6 ± 3.1 || 3(2–4) | 3.8 ± 3.4 || 3(2–4) | 3.4 ± 2.9 || 2.5(2–4) | 0.11 |
Death before day 28b | 7 (1%) | 1 (1%) | 6 (2%) | 0.39 |
Transfusion | ||||
Whole hospital stay | (n = 495) | (n = 185) | (n = 310) | |
All products transfusionb | 183 (37%) | 78 (42%) | 105 (33%) | 0.07 |
RBC (number of unit)a | 0.75 ± 1.6 || 0(0–1) | 0.83 ± 1.9 || 0(0–2) | 0.23 ± 0.5 || 0(0–0.33) | 0.27 |
RBC (proportion)b | 141 (28%) | 58 (31%) | 83 (26%) | 0.28 |
Intraoperative | ||||
All products transfusionb | 118 (24%) | 57 (31%) | 61 (19%) | 0.005 |
RBC (number of unit)a | 0.34 ± 0.9 || 0(0–0) | 0.46 ± 1.0 || 0(0–0) | 0.26 ± 0.8 || 0(0–0) | 0.010 |
RBC (proportion)b | 81 (16%) | 40 (22%) | 41 (13%) | 0.017 |
Retransfusion (ml)a | 589 ± 350 || 522(433–715) | 606 ± 387 || 541(437–737) | 578 ± 327 || 514(432–710) | 0.50 |
ICU | ||||
All products transfusionb | 88 (18%) | 26 (14%) | 62 (20%) | 0.14 |
RBC (number of unit)a | 0.36 ± 1.2 || 0(0–0) | 0.27 ± 1.4 || 0(0–0) | 0.41 ± 1.2 || 0(0–0) | 0.14 |
RBC (proportion)b | 73 (15%) | 20 (11%) | 53 (17%) | 0.09 |
Surgical department | (n = 495) | (n = 185) | (n = 310) | |
RBC (number of unit)a | 0.09 ± 0.4 || 0(0–0) | 0.12 ± 0.5 || 0(0–0) | 0.08 ± 0.4 || 0(0–0) | 0.45 |
RBC (proportion)b | 25 (5%) | 11 (6%) | 14 (5%) | 0.59 |